Pulmonary Valve Replacement in Tetralogy of Fallot
Author(s) -
David M. Harrild,
Charles I. Berul,
Frank Cecchin,
Tal Geva,
Kimberlee Gauvreau,
Frank A. Pigula,
Edward P. Walsh
Publication year - 2009
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.108.775221
Subject(s) - medicine , tetralogy of fallot , cardiology , pulmonary valve , pulmonary valve insufficiency , heart disease , pulmonary regurgitation
Pulmonary valve replacement (PVR) in repaired tetralogy of Fallot (TOF) reduces pulmonary regurgitation and decreases right ventricular (RV) dilation, but its long-term impact on ventricular tachycardia (VT) and mortality is unknown. This study aimed to determine the incidence of death and VT in TOF after PVR and to test the hypothesis that PVR leads to improvement in these outcomes.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom